EPFL - Idorsia Joint Symposium


Event details

Date and time 31.01.2020 13:0018:00  
Place and room
Speaker EPFL: Bruno Correia, Michele De Palma, Bart Deplancke, Federico Giberti, Felix Naef, Philippe Renaud, Gisou van der Goot, Martin Vetterli Idorsia: Martine Clozel, Julien Hazemann, Cedric Leroy, Elisa Liberatore, Christoph Sager, Catherine Vaillant
Category Conferences - Seminars

The symposium aims to tighten the relationship between EPFL and Idorsia, a Basel based biopharmaceutical company specialized in the discovery and development of small molecules to provide innovative therapeutic possibilities. Presentations and discussions will explore potential research and students collaborations.

A unique opportunity to exchange with actors from industry. The School of Life Sciences Innovation initiative Catalyze4Life encourage scientists and students interested in biopharmaceutical developments to attend.

Free registration required


  • 13:00 Welcoming wordGisou van der Goot, School of Life Sciences Dean
  • 13:10 Welcoming word Martine Clozel, Idorsia CSO
  • 13:20 'Microfluidic flow cytometry' Philippe Renaud, EPFL
  • 13:40 'Leveraging Orexin receptor structures for drug design Christoph Sager and Catherine Vaillant, Idorsia
  • 14:00 'Rational protein design driving innovation towards novel biologics and cell-based therapies' Bruno Correia, EPFL
  • 14:20 'Pyruvate Dehydrogenase Kinase (PDHK): a difficult to reach but appealing cancer target' – Cedric Leroy, Idorsia 14:40
  • Coffee Break
  • 15:20 'Perspective of industry projects for Master students' Felix Naef, EPFL
  • 15:40 'Atomistic modelling of stability and properties of drug molecules with machine learning' – Federico Giberti, EPFL
  • 16:00 ‘Challenges in Maching Learning-assisted Drug Design (MLDD)’ – part IJulien Hazemann and Lisa Liberatore, Idorsia
  • 16:20 ‘Engineering dentritic cell vaccines for cancer immunotherapy’ Miki De Palma, EPFL
  • 16:40 ‘Challenges in Maching Learning-assisted Drug Design (MLDD)’ – part IIJulien Hazemann and Elisa Liberatore, Idorsia
  • 17:00 Closing comments Martin Vetterli, EPFL President
  • 17:10 ‘How to strenghten ties between EPFL and Idorsia’ – Discussion (on invitation only)
  • 18:30 End of Symposium

Practical information

  • Informed public
  • Registration required


  • EFPL School of Life Sciences - Catalyze4Life


  • Bart Deplancke


Master industry projects Catalyze4Life industry relation biopharma